JP2002508773A5 - - Google Patents

Download PDF

Info

Publication number
JP2002508773A5
JP2002508773A5 JP1999505984A JP50598499A JP2002508773A5 JP 2002508773 A5 JP2002508773 A5 JP 2002508773A5 JP 1999505984 A JP1999505984 A JP 1999505984A JP 50598499 A JP50598499 A JP 50598499A JP 2002508773 A5 JP2002508773 A5 JP 2002508773A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP1999505984A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002508773A (ja
Filing date
Publication date
Priority claimed from BE9700572A external-priority patent/BE1011251A3/fr
Application filed filed Critical
Publication of JP2002508773A publication Critical patent/JP2002508773A/ja
Publication of JP2002508773A5 publication Critical patent/JP2002508773A5/ja
Withdrawn legal-status Critical Current

Links

JP50598499A 1997-07-03 1998-07-02 活性物質及びシクロデキストリンを含有する経口投与用医薬剤 Withdrawn JP2002508773A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
BE9700572A BE1011251A3 (fr) 1997-07-03 1997-07-03 Compositions pharmaceutiques administrables par voie orale, comprenant une substance active et une cyclodextrine.
BE9700572 1997-07-03
PCT/BE1998/000100 WO1999001133A1 (fr) 1997-07-03 1998-07-02 Compositions pharmaceutiques administrables par voie orale, comprenant une substance active et une cyclodextrine

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2007004722A Division JP2007091760A (ja) 1997-07-03 2007-01-12 活性物質及びシクロデキストリンを含有する経口投与用医薬剤

Publications (2)

Publication Number Publication Date
JP2002508773A JP2002508773A (ja) 2002-03-19
JP2002508773A5 true JP2002508773A5 (enExample) 2006-10-26

Family

ID=3890611

Family Applications (2)

Application Number Title Priority Date Filing Date
JP50598499A Withdrawn JP2002508773A (ja) 1997-07-03 1998-07-02 活性物質及びシクロデキストリンを含有する経口投与用医薬剤
JP2007004722A Pending JP2007091760A (ja) 1997-07-03 2007-01-12 活性物質及びシクロデキストリンを含有する経口投与用医薬剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2007004722A Pending JP2007091760A (ja) 1997-07-03 2007-01-12 活性物質及びシクロデキストリンを含有する経口投与用医薬剤

Country Status (20)

Country Link
US (1) US6455533B1 (enExample)
EP (1) EP0994710B2 (enExample)
JP (2) JP2002508773A (enExample)
KR (1) KR100551510B1 (enExample)
CN (1) CN1150900C (enExample)
AT (1) ATE224717T1 (enExample)
AU (1) AU727140B2 (enExample)
BE (1) BE1011251A3 (enExample)
BR (1) BR9810495A (enExample)
CA (1) CA2294783C (enExample)
DE (1) DE69808297T3 (enExample)
DK (1) DK0994710T4 (enExample)
ES (1) ES2184293T5 (enExample)
ID (1) ID23806A (enExample)
IL (1) IL133397A (enExample)
NZ (1) NZ501820A (enExample)
PL (1) PL192348B1 (enExample)
PT (1) PT994710E (enExample)
RU (1) RU2192863C2 (enExample)
WO (1) WO1999001133A1 (enExample)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0028575D0 (en) * 2000-11-23 2001-01-10 Elan Corp Plc Oral pharmaceutical compositions containing cyclodextrins
US20040213839A1 (en) * 2001-02-05 2004-10-28 Andrew Favara Methods and compositions for reducing the taste of pharmaceutically active agents
NZ534039A (en) * 2002-01-15 2006-08-31 Ucb Farchim S Formulations of pharmaceutical compositions for oral administration
PL372904A1 (en) * 2002-04-04 2005-08-08 Pfizer Products Inc. Palatable chewable tablet
CA2574602A1 (en) * 2004-07-22 2006-02-02 Pfizer Products Inc. Taste masking formulation comprising the drug in a dissolution-retarded form and/or cyclodextrin in a dissolution-enhanced form
US20060147518A1 (en) * 2004-12-30 2006-07-06 Pierre Fabre Medicament Stable solid dispersion of a derivative of vinca alkaloid and process for manufacturing it
US20060198885A1 (en) * 2005-02-22 2006-09-07 Sun Pharmaceutical Industries Ltd. Oral pharmaceutical composition
US20070086974A1 (en) * 2005-10-06 2007-04-19 Gawande Rahul S Cetirizine compositions
US20090269393A1 (en) * 2006-06-12 2009-10-29 Jubliant Organosys Limited Chewable Bilayer Tablet Formulation
JP2008143807A (ja) * 2006-12-07 2008-06-26 Sato Pharmaceutical Co Ltd 感冒薬カプセル剤及びその製造方法
EP2550967A1 (en) * 2007-07-11 2013-01-30 Fertin Pharma A/S Compressed chewing gum tablet comprising taste-masking agent
US20100260818A1 (en) * 2007-07-11 2010-10-14 Fertin Pharma A/S Stable medicated chewing gum comprising cyclodextrin inclusion complex
WO2009054432A1 (ja) * 2007-10-26 2009-04-30 Daiichi Sankyo Company, Limited 口腔内速崩壊性医薬組成物およびその製造方法
US8138192B2 (en) * 2007-10-31 2012-03-20 Genebiology, Inc. Injectable meclizine formulations and methods
WO2009061465A1 (en) * 2007-11-06 2009-05-14 Teva Pharmaceutical Industries Ltd. Chewable formulations
ES2564056T3 (es) * 2008-09-05 2016-03-17 Johnson & Johnson Consumer Inc. Método para hacer pastillas de cetirizina
WO2011110939A2 (en) 2010-03-11 2011-09-15 Rubicon Research Private Limited Pharmaceutical compositions of substituted benzhydrylpiperazines
WO2011150859A1 (en) * 2010-06-04 2011-12-08 Comprehensive Drug Enterprises Ltd Oral meclizine aqueous formulations with taste flavoring agent
CN101905027A (zh) * 2010-07-27 2010-12-08 北京华禧联合科技发展有限公司 含米格列奈钙和环糊精的口服药用组合物
AU2011302293B2 (en) 2010-09-13 2015-11-26 Bev-Rx, Inc. Aqueous drug delivery system comprising off - flavor masking agent
US9945862B2 (en) 2011-06-03 2018-04-17 Eisai R&D Management Co., Ltd. Biomarkers for predicting and assessing responsiveness of thyroid and kidney cancer subjects to lenvatinib compounds
RU2589833C2 (ru) * 2013-12-12 2016-07-10 Общество С Ограниченной Ответственностью "Фарма Старт" Твердая лекарственная форма препарата седативного и снотворного действия
DK3122330T3 (en) * 2014-03-27 2018-10-22 Ucb Farchim Sa Pharmaceutical compositions comprising levocetirizine
IL302218B2 (en) 2014-08-28 2024-10-01 Eisai R&D Man Co Ltd Methods for manufacturing high-purity lenvatinib and its derivatives
JP6792546B2 (ja) 2015-02-25 2020-11-25 エーザイ・アール・アンド・ディー・マネジメント株式会社 キノリン誘導体の苦味抑制方法
AU2015384801B2 (en) 2015-03-04 2022-01-06 Eisai R&D Management Co., Ltd. Combination of a PD-1 antagonist and a VEGFR/FGFR/RET tyrosine kinase inhibitor for treating cancer
EP3311841B1 (en) 2015-06-16 2021-07-28 PRISM BioLab Co., Ltd. Anticancer agent
CN108135894B (zh) 2015-08-20 2021-02-19 卫材R&D管理有限公司 肿瘤治疗剂
RU2750539C2 (ru) 2017-02-08 2021-06-29 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Фармацевтическая композиция для лечения опухоли
AU2018269996A1 (en) 2017-05-16 2019-11-21 Eisai R&D Management Co., Ltd. Treatment of hepatocellular carcinoma
KR102110304B1 (ko) * 2017-06-30 2020-05-14 한미약품 주식회사 레보세티리진 및 몬테루카스트를 포함하는 안정성 및 복약순응도가 향상된 복합 츄어블정 및 그 제조방법
EP4099977A1 (en) * 2020-02-03 2022-12-14 Johnson & Johnson Consumer Inc. A single layer chewable tablet comprising cetirizine
WO2022106923A1 (en) 2020-11-18 2022-05-27 BioPharma Synergies, S. L. Orodispersible powder composition comprising an antihistamine compound

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK154078C (da) * 1981-02-06 1989-05-22 Ucb Sa Analogifremgangsmaade til fremstilling af 2-(2-(4-(diphenyl-methyl)-1-piperazinyl)ethoxy)-acetamider eller syreadditionssalte heraf
JPS58177949A (ja) * 1982-04-12 1983-10-18 Takeda Chem Ind Ltd ランカシジン群抗生物質包接化合物
JPS60204712A (ja) * 1984-03-29 1985-10-16 Ss Pharmaceut Co Ltd 塩酸メクリジンの安定化液状組成物
JPS63243031A (ja) 1987-03-28 1988-10-07 Tokyo Tanabe Co Ltd 胆汁酸の固形製剤
FR2647343B1 (fr) * 1989-05-24 1994-05-06 Rhone Poulenc Sante Nouvelle forme pharmaceutique poreuse et sa preparation
US5206025A (en) * 1989-05-24 1993-04-27 Rhone-Poulenc Sante Porous pharmaceutical form and its preparation
CA2145410A1 (en) 1992-09-24 1994-03-31 Nancy M. Gray Compositions for treating allergic disorders using (-) cetirizine
TW401300B (en) * 1992-12-25 2000-08-11 Senju Pharma Co Antiallergic composition for ophthalmic or nasal use
ES2166811T3 (es) * 1993-12-01 2002-05-01 Byk Gulden Lomberg Chem Fab Amino-alquil-amino-piridinas sustituidas.
US5866179A (en) 1996-05-03 1999-02-02 Avant-Garde Technologies & Products S.A. Medicated chewing gum and a process for preparation thereof
GB0028575D0 (en) * 2000-11-23 2001-01-10 Elan Corp Plc Oral pharmaceutical compositions containing cyclodextrins
CA2574602A1 (en) * 2004-07-22 2006-02-02 Pfizer Products Inc. Taste masking formulation comprising the drug in a dissolution-retarded form and/or cyclodextrin in a dissolution-enhanced form

Similar Documents

Publication Publication Date Title
JP2000510751A5 (enExample)
JP2002511841A5 (enExample)
JP2000509637A5 (enExample)
JP2000509635A5 (enExample)
JP2000507042A5 (enExample)
JP2002514117A5 (enExample)
JP2001507518A5 (enExample)
JP2000509587A5 (enExample)
JP2000507369A5 (enExample)
JP2000507433A5 (enExample)
JP2001505753A5 (enExample)
JP2001511149A5 (enExample)
JP2000508866A5 (enExample)
JP2002503179A5 (enExample)
JP2000508022A5 (enExample)
JP2000508841A5 (enExample)
JP2000508680A5 (enExample)
JP2002508773A5 (enExample)
JP2000509755A5 (enExample)
JP2000510969A5 (enExample)
JP2000508836A5 (enExample)
JP2000508102A5 (enExample)
JP2000509520A5 (enExample)
JP2000507434A5 (enExample)
JP2000508880A5 (enExample)